Developing

Have Produced 40 Million Doses Of AstraZeneca Covid-19 Vaccine: Serum On Thursday

Serum Institute of India, the world’s largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca’s potential Covid-19 vaccine, and would soon begin making Novavax’s rival shot, as they both seek regulatory approval. Serum said it has enrolled 1,600 participants in India for late-stage trials of AstraZeneca’s candidate, and also plans to seek regulatory approval to run late-stage trials for the Novavax vaccine. The AstraZeneca vaccine, co-developed by Oxford University, is the most advanced in human testing in India, Serum said.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

To Top